February 7, 2023 KKR & Co. Inc. Overview Presentation – 4Q'25 March 2026 Legal Disclosures This presentation has been prepared by KKR & Co. Inc. solely for informational purposes for its public stockholders in connection with evaluating the business, operations and financial results of KKR & Co. Inc. and its subsidiaries (collectively, "KKR"), which includes The Global Atlantic Financial Group LLC and its subsidiaries (collectively, "Global Atlantic" or "GA"), unless the context requires otherwise. This pre ...

Q4 & FY 2025 Earnings Call Presentation March │ 2026 1 Disclaimer This presentation has been prepared by Auna S.A. ("Auna" or the "Company") solely for use at this presentation. This presentation is confidential to the recipient. Accordingly, any attempt to copy, summarize or distribute this presentation or any portion hereof in any form to any other party without the Company's prior written consent is prohibited. This presentation contains forward-looking statements. Forward-looking statements convey our c ...

4Q25 INVESTOR PRESENTATION March 2026 Guyu_Cover.ai \\firmwide.corp.gs.com\ibdro \\firmwide.corp.gs.com\ibdro ot\projects\IBD- HK\soundman2020\664232 _1\Graphics\Ai\01_Project Guyu_Cover.ai \\firmwide.corp.gs.com\ibdro ot\projects\IBD- HK\soundman2020\664232 _1\Graphics\JPEG\01_Proj ect Guyu_Cover-01.jpg \\firmwide.corp.gs.com\ibdro ot\projects\IBD- HK\soundman2020\664232 _1\Graphics\Ai\01_Project ot\projects\IBD- HK\soundman2020\664232 _1\Graphics\JPEG\01_Proj ect Guyu_Cover-01.jpg 02 June 2021 Safe Harbor ...

Medium-Term Plan February 2026 Paper | Packaging | Solutions Smurfit Westrock | Medium-Term Plan 2 Forward Looking Statements and Non-GAAP Financial Measures The presentation includes certain "forward-looking statements" (including within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) regarding, among other things, the plans, strategies, outcomes, outlooks, and prospects, both business and financial, of Smurfit Westro ...

INVESTOR PRESENTATION MARCH 2026 DISCLAIMER This presentation contains a number of forward-looking statements. Words, and variations of words, such as "will," "can," "may," "expect," "would," "could," "might," "intend," "plan," "believe," "estimate," "anticipate," "deliver," "seek," "aim," "potential," "target," "outlook," and similar expressions are intended to identify forward-looking statements. Such forward- looking statements include those that address activities, events or developments that Pursuit or ...

Drive for better vision : HIMX February 2026 INVESTOR PRESENTATION Forward Looking Statements Factors that could cause actual events or results to differ materially from those described in this conference call include, but are not limited to, the effect of the Covid-19 pandemic on the Company's business; general business and economic conditions and the state of the semiconductor industry; market acceptance and competitiveness of the driver and non-driver products developed by the Company; demand for end-use ...

INVESTOR PRESENTATION MARCH 2026 NON-GAAP AND OTHER FINANCIAL MEASURES In addition to the IFRS prepared results and balances presented in the Trust's condensed consolidated interim financial statements and the notes thereto, Alaris uses a number of other financial measures to monitor its performance and some of these are presented in this investor presentation. These measures may not have standardized meanings or computations as prescribed by IFRS that would ensure consistency and comparability between comp ...

Investor Presentation 2026 Autonomous robotics at scale. LEGAL Forward-Looking Statements & Disclaimers This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are not historical facts or guarantees of future performance. Forward-looking statements include statements regarding the Company's future revenue generation, business and investment strategy, ...

Forward-Looking Statements This presentation contains forward-looking statements regarding Kyntra Bio's strategy, future plans and prospects, including statements regarding its commercial products and clinical programs and those of its partners Fortis and UCSF. These forward-looking statements include, but are not limited to, statements regarding the efficacy, safety, and potential clinical or commercial success of Kyntra Bio products and product candidates, statements under the caption "Recent and Near-Ter ...

ImmunityBio Investor Presentation March 2026 1 Forward-Looking Statements and Intended Use This presentation and the accompanying verbal remarks contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding data and results from clinical trials and potential implications therefrom, commercialization plans and timelines, including product availability and shipments, potential regulatory pathways and approval requests and submission ...